Terc (telomerase RNA component) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Pathways
Gene: Terc (telomerase RNA component) Mus musculus
Analyze
Symbol: Terc
Name: telomerase RNA component
RGD ID: 1616824
MGI Page MGI
Description: Enables telomerase activity. Acts upstream of or within several processes, including DNA metabolic process; determination of adult lifespan; and hemopoiesis. Is expressed in embryo. Used to study Duchenne muscular dystrophy; Werner syndrome; and osteoporosis.
Type: ncrna (Ensembl: lncRNA)
RefSeq Status: REVIEWED
Previously known as: mT; mTE; mTER; mTR
RGD Orthologs
Human
Rat
Alliance Genes
More Info more info ...
Latest Assembly: GRCm39 - Mouse Genome Assembly GRCm39
Position:
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39396,321,753 - 96,322,149 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl396,321,753 - 96,322,149 (-)EnsemblGRCm39 Ensembl
GRCm38396,414,437 - 96,414,833 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl396,414,437 - 96,414,859 (-)EnsemblGRCm38mm10GRCm38
GRCm38.p6 Ensembl396,414,437 - 96,414,833 (-)EnsemblGRCm38mm10GRCm38
MGSCv37396,218,360 - 96,218,756 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36396,499,842 - 96,500,238 (-)NCBIMGSCv36mm8
Celera397,832,081 - 97,832,477 (-)NCBICelera
Cytogenetic Map3F2.1NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Phenotype Annotations     Click to see Annotation Detail View

Mammalian Phenotype
abnormal adipose tissue distribution  (IAGP)
abnormal angiogenesis  (IAGP)
abnormal blood cell morphology/development  (IAGP)
abnormal bone marrow morphology  (IAGP)
abnormal bone ossification  (IAGP)
abnormal bone trabecula morphology  (IAGP)
abnormal cardiac muscle contractility  (IAGP)
abnormal cardiac muscle relaxation  (IAGP)
abnormal cardiovascular system physiology  (IAGP)
abnormal cell physiology  (IAGP)
abnormal chromosome morphology  (IAGP)
abnormal compact bone morphology  (IAGP)
abnormal crypts of Lieberkuhn morphology  (IAGP)
abnormal definitive hematopoiesis  (IAGP)
abnormal developmental patterning  (IAGP)
abnormal diaphragm morphology  (IAGP)
abnormal DNA repair  (IAGP)
abnormal enterocyte proliferation  (IAGP)
abnormal erythrocyte morphology  (IAGP)
abnormal female meiosis  (IAGP)
abnormal femur morphology  (IAGP)
abnormal fetal cardiomyocyte proliferation  (IAGP)
abnormal granulocyte morphology  (IAGP)
abnormal intestine morphology  (IAGP)
abnormal male meiosis  (IAGP)
abnormal meiosis  (IAGP)
abnormal mitochondrial shape  (IAGP)
abnormal muscle electrophysiology  (IAGP)
abnormal muscle physiology  (IAGP)
abnormal myocardial fiber morphology  (IAGP)
abnormal nail morphology  (IAGP)
abnormal oocyte morphology  (IAGP)
abnormal osteoid morphology  (IAGP)
abnormal skeletal muscle morphology  (IAGP)
abnormal skeleton physiology  (IAGP)
abnormal spermatid morphology  (IAGP)
abnormal spermatocyte morphology  (IAGP)
abnormal spermatogenesis  (IAGP)
abnormal spleen B cell follicle morphology  (IAGP)
abnormal telomere length  (IAGP)
absent bone marrow cell  (IAGP)
alopecia  (IAGP)
anemia  (IAGP)
calcified muscle  (IAGP)
cardiac fibrosis  (IAGP)
cardiac hypertrophy  (IAGP)
cataract  (IAGP)
centrally nucleated skeletal muscle fibers  (IAGP)
chromosomal instability  (IAGP)
congestive heart failure  (IAGP)
decreased B cell proliferation  (IAGP)
decreased body size  (IAGP)
decreased body weight  (IAGP)
decreased bone trabecula number  (IAGP)
decreased bone volume  (IAGP)
decreased cell proliferation  (IAGP)
decreased compact bone area  (IAGP)
decreased compact bone thickness  (IAGP)
decreased erythrocyte cell number  (IAGP)
decreased fetal size  (IAGP)
decreased granulocyte number  (IAGP)
decreased heart left ventricle weight  (IAGP)
decreased heart weight  (IAGP)
decreased hematopoietic stem cell number  (IAGP)
decreased incidence of induced tumors  (IAGP)
decreased incidence of tumors by chemical induction  (IAGP)
decreased left ventricle developed pressure  (IAGP)
decreased leukocyte cell number  (IAGP)
decreased litter size  (IAGP)
decreased locomotor activity  (IAGP)
decreased male germ cell number  (IAGP)
decreased mitochondrial size  (IAGP)
decreased myocardial fiber number  (IAGP)
decreased satellite cell number  (IAGP)
decreased spleen germinal center number  (IAGP)
decreased subcutaneous adipose tissue amount  (IAGP)
decreased T cell proliferation  (IAGP)
decreased telomere length  (IAGP)
decreased trabecular bone mass  (IAGP)
decreased trabecular bone thickness  (IAGP)
decreased ventricle muscle contractility  (IAGP)
delayed wound healing  (IAGP)
dilated cardiomyopathy  (IAGP)
dilated heart left ventricle  (IAGP)
disorganized mitochondrial cristae  (IAGP)
dry skin  (IAGP)
dystrophic muscle  (IAGP)
focal hair loss  (IAGP)
fragile skeleton  (IAGP)
heart left ventricle hypertrophy  (IAGP)
hyperglycemia  (IAGP)
hyperpigmentation  (IAGP)
impaired exercise endurance  (IAGP)
impaired glucose tolerance  (IAGP)
impaired hematopoiesis  (IAGP)
impaired wound healing  (IAGP)
increased apoptosis  (IAGP)
increased B cell apoptosis  (IAGP)
increased bone trabecular spacing  (IAGP)
increased carcinoma incidence  (IAGP)
increased cardiomyocyte apoptosis  (IAGP)
increased circulating creatine kinase level  (IAGP)
increased circulating insulin level  (IAGP)
increased embryonic tissue cell apoptosis  (IAGP)
increased enterocyte apoptosis  (IAGP)
increased heart left ventricle size  (IAGP)
increased left ventricle diastolic pressure  (IAGP)
increased lymphoma incidence  (IAGP)
increased male germ cell apoptosis  (IAGP)
increased mitochondrial number  (IAGP)
increased osteosarcoma incidence  (IAGP)
increased sarcoma incidence  (IAGP)
increased tumor incidence  (IAGP)
increased variability of skeletal muscle fiber size  (IAGP)
infertility  (IAGP)
kyphosis  (IAGP)
muscle weakness  (IAGP)
muscular atrophy  (IAGP)
myositis  (IAGP)
open neural tube  (IAGP)
osteoporosis  (IAGP)
oxidative stress  (IAGP)
pancytopenia  (IAGP)
postnatal lethality, complete penetrance  (IAGP)
premature aging  (IAGP)
premature death  (IAGP)
prenatal lethality, complete penetrance  (IAGP)
prenatal lethality, incomplete penetrance  (IAGP)
prolonged QRS complex duration  (IAGP)
reduced female fertility  (IAGP)
respiratory failure  (IAGP)
skeletal muscle degeneration  (IAGP)
skeletal muscle fibrosis  (IAGP)
skeletal muscle necrosis  (IAGP)
small gonad  (IAGP)
small testis  (IAGP)
testicular atrophy  (IAGP)
thrombocytopenia  (IAGP)
ventricular cardiomyopathy  (IAGP)
weight loss  (IAGP)
References

References - curated
# Reference Title Reference Citation
1. Expression of telomerase subunits in gastric cancer. Chen F, etal., J Huazhong Univ Sci Technolog Med Sci. 2005;25(6):741-3. doi: 10.1007/BF02896189.
2. Telomerase RNA as a detection marker in the serum of breast cancer patients. Chen XQ, etal., Clin Cancer Res. 2000 Oct;6(10):3823-6.
3. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor. Dome JS, etal., J Clin Oncol. 2005 Dec 20;23(36):9138-45. Epub 2005 Sep 19.
4. Gene amplifications associated with the development of hormone-resistant prostate cancer. Edwards J, etal., Clin Cancer Res. 2003 Nov 1;9(14):5271-81.
5. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer. Eissa S, etal., J Urol. 2007 Sep;178(3 Pt 1):1068-72. Epub 2007 Jul 20.
6. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer. Heselmeyer-Haddad K, etal., Am J Pathol. 2005 Apr;166(4):1229-38.
7. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. Hopman AH, etal., J Pathol. 2006 Dec;210(4):412-9.
8. The effect on melanoma risk of genes previously associated with telomere length. Iles MM, etal., J Natl Cancer Inst. 2014 Sep 17;106(10). pii: dju267. doi: 10.1093/jnci/dju267. Print 2014 Oct.
9. Telomere length, telomerase activity and telomerase RNA expression during mouse mammary tumor progression. Kiyozuka Y, etal., Int J Mol Med. 1998 Oct;2(4):437-44.
10. Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation. Leuenroth S, etal., BJU Int. 2005 Sep;96(4):553-7.
11. Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. Montanaro L, etal., J Pathol. 2006 Sep;210(1):10-8.
12. Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract. Nakanishi K, etal., Cancer. 1999 Nov 15;86(10):2109-16.
13. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer. Novakovic S, etal., Oncol Rep. 2004 Jan;11(1):245-52.
14. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
15. In situ nucleic acid detection of human telomerase in intrahepatic cholangiocarcinoma and its preneoplastic lesion. Ozaki S, etal., Hepatology. 1999 Oct;30(4):914-9. doi: 10.1002/hep.510300419.
16. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. Poremba C, etal., J Pathol. 2002 Oct;198(2):181-9.
17. Mouse MP Annotation Import Pipeline RGD automated import pipeline
18. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
19. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
20. Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue. Rohde V, etal., Clin Cancer Res. 2000 Dec;6(12):4803-9.
21. Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours. Wisman GB, etal., Int J Oncol. 2003 Nov;23(5):1451-9.
Additional References at PubMed
PMID:7544492   PMID:8563761   PMID:9143511   PMID:9328462   PMID:9334263   PMID:9334336   PMID:9335332   PMID:9421511   PMID:9546436   PMID:9560153   PMID:9620783   PMID:9724727  
PMID:9988222   PMID:10037783   PMID:10064584   PMID:10089885   PMID:10338215   PMID:10338216   PMID:10349636   PMID:10357808   PMID:10458601   PMID:10497259   PMID:10583505   PMID:10654945  
PMID:10678830   PMID:10721988   PMID:10949306   PMID:10973255   PMID:10973262   PMID:11042159   PMID:11076861   PMID:11217851   PMID:11381263   PMID:11407947   PMID:11595186   PMID:11753387  
PMID:11788723   PMID:11809709   PMID:11882542   PMID:11904421   PMID:11929765   PMID:11950883   PMID:11980718   PMID:12034875   PMID:12113474   PMID:12204535   PMID:12217319   PMID:12426399  
PMID:12466851   PMID:12504888   PMID:12505991   PMID:12514102   PMID:12514136   PMID:12540856   PMID:12663456   PMID:12881434   PMID:12941829   PMID:12944479   PMID:14612493   PMID:14678974  
PMID:14688198   PMID:14731390   PMID:14980495   PMID:15084742   PMID:15148368   PMID:15235603   PMID:15258806   PMID:15269166   PMID:15282303   PMID:15319283   PMID:15322096   PMID:15367665  
PMID:15488760   PMID:15545322   PMID:15608677   PMID:15731767   PMID:15860505   PMID:15893973   PMID:15927211   PMID:15965466   PMID:16037417   PMID:16107853   PMID:16141072   PMID:16141073  
PMID:16142233   PMID:16213831   PMID:16264192   PMID:16360040   PMID:16467146   PMID:16582880   PMID:16831983   PMID:16839877   PMID:16880523   PMID:16973670   PMID:17072335   PMID:17143283  
PMID:17145779   PMID:17234886   PMID:17237781   PMID:17360455   PMID:17396137   PMID:17433324   PMID:17433785   PMID:17486088   PMID:17515920   PMID:17554309   PMID:17785530   PMID:17803909  
PMID:17954610   PMID:17982445   PMID:18028256   PMID:18157120   PMID:18223679   PMID:18283039   PMID:18283121   PMID:18448098   PMID:18451164   PMID:18550783   PMID:18593874   PMID:18599611  
PMID:18626023   PMID:18695223   PMID:18718525   PMID:18799693   PMID:18936156   PMID:18952756   PMID:18986375   PMID:19180191   PMID:19188698   PMID:19200803   PMID:19295915   PMID:19482563  
PMID:19605693   PMID:19718028   PMID:19850716   PMID:19887628   PMID:19923274   PMID:19944403   PMID:19959722   PMID:19965646   PMID:20160708   PMID:20212315   PMID:20226664   PMID:20231318  
PMID:20577265   PMID:20588252   PMID:20633556   PMID:20686699   PMID:20864668   PMID:20876939   PMID:20926734   PMID:21113150   PMID:21145579   PMID:21183068   PMID:21187328   PMID:21308778  
PMID:21364961   PMID:21423765   PMID:21426483   PMID:21460122   PMID:21593138   PMID:21672962   PMID:21903669   PMID:21948176   PMID:22138576   PMID:22284665   PMID:22341440   PMID:22385964  
PMID:22408137   PMID:22621437   PMID:22622037   PMID:22855157   PMID:23019197   PMID:23159929   PMID:23288511   PMID:23526226   PMID:23831727   PMID:24268696   PMID:24449270   PMID:24531712  
PMID:24626990   PMID:24733392   PMID:24920220   PMID:24960204   PMID:25038516   PMID:25194572   PMID:25232057   PMID:25233189   PMID:25464850   PMID:25479751   PMID:25499762   PMID:25550449  
PMID:25609789   PMID:25892207   PMID:25893605   PMID:25921537   PMID:26266089   PMID:26518879   PMID:26584619   PMID:26968134   PMID:27088856   PMID:27241915   PMID:27586969   PMID:27653523  
PMID:27799523   PMID:27823970   PMID:28303901   PMID:28346225   PMID:28514651   PMID:28855418   PMID:29290468   PMID:29351466   PMID:29590618   PMID:29599138   PMID:29698462   PMID:29880812  
PMID:30126922   PMID:30179220   PMID:30650360   PMID:30737259   PMID:30788732   PMID:30811824   PMID:30870992   PMID:31488579   PMID:31511695   PMID:31518356   PMID:32127537   PMID:32467172  
PMID:33303684   PMID:33357405   PMID:34205454   PMID:34831112   PMID:34854526   PMID:35426375  


Genomics

Comparative Map Data
Terc
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39396,321,753 - 96,322,149 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl396,321,753 - 96,322,149 (-)EnsemblGRCm39 Ensembl
GRCm38396,414,437 - 96,414,833 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl396,414,437 - 96,414,859 (-)EnsemblGRCm38mm10GRCm38
GRCm38.p6 Ensembl396,414,437 - 96,414,833 (-)EnsemblGRCm38mm10GRCm38
MGSCv37396,218,360 - 96,218,756 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36396,499,842 - 96,500,238 (-)NCBIMGSCv36mm8
Celera397,832,081 - 97,832,477 (-)NCBICelera
Cytogenetic Map3F2.1NCBI
TERC
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh383169,764,610 - 169,765,060 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p13 Ensembl3169,764,520 - 169,765,060 (-)EnsemblGRCh38hg38GRCh38
GRCh38.p13 Ensembl3169,764,610 - 169,765,047 (-)EnsemblGRCh38hg38GRCh38
GRCh373169,482,398 - 169,482,848 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 363170,965,092 - 170,965,542 (-)NCBINCBI36Build 36hg18NCBI36
Celera3167,881,540 - 167,881,990 (-)NCBICelera
Cytogenetic Map3q26.2NCBI
HuRef3166,852,038 - 166,852,488 (-)NCBIHuRef
CHM1_13169,445,476 - 169,445,926 (-)NCBICHM1_1
T2T-CHM13v2.03172,548,562 - 172,549,012 (-)NCBIT2T-CHM13v2.0
Terc
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.22112,815,654 - 112,816,041 (+)NCBImRatBN7.2mRatBN7.2
UTH_Rnor_SHR_Utx2119,466,989 - 119,467,376 (+)NCBIRnor_SHR
UTH_Rnor_SHRSP_BbbUtx_1.02117,579,552 - 117,579,939 (+)NCBIRnor_SHRSP
UTH_Rnor_WKY_Bbb_1.02112,290,386 - 112,290,773 (+)NCBIRnor_WKY
Rnor_6.02116,432,723 - 116,433,110 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl2116,432,691 - 116,433,110 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.02136,126,300 - 136,126,687 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.42117,234,446 - 117,234,833 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.12117,179,407 - 117,179,795 (+)NCBI
Celera2107,993,694 - 107,994,082 (+)NCBICelera
Cytogenetic Map2q24NCBI

Variants

.
Variants in Terc
14 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:229
Count of miRNA genes:214
Interacting mature miRNAs:229
Transcripts:ENSMUST00000082862
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCm39)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
26884436Zlq3_mzygomatic length QTL 3, 10 week (mouse)33265060142405761Mouse
4142399Aec1_mautoimmune exocrinopathy 1 (mouse)Not determined7586174102690034Mouse
26884427Cvht4_mcranial vault height 4, 10 week (mouse)316054164109707316Mouse
13207570Tcq12_mtotal cholesterol QTL 12 (mouse)316504164130163649Mouse
26884422Cvht7_mcranial vault height 7, 16 week (mouse)328954149118893649Mouse
1302056Orgwq4_morgan weight QTL 4 (mouse)Not determined330067588147304689Mouse
1301705Sles3_msystemic lupus erythmatosus suppressor 3 (mouse)Not determined337174862143353183Mouse
13208566Bmiq5_mbody mass index QTL 5 (mouse)340954435115793649Mouse
26884380Skwq1_mskull length QTL 1, 5 week (mouse)343954435101607316Mouse
26884378Skwq6_mskull length QTL 6, 10 week (mouse)351907421102307316Mouse
26884382Bzwq1_mbi-zygomatic width QTL 1, 5 week (mouse)352207421137205761Mouse
11039519Ltpr3_mLeishmania tropica response 3 (mouse)356704102100464137Mouse
1301971Cia5_mcollagen induced arthritis QTL 5 (mouse)Not determined366046658100046795Mouse
25314313Syncl1_msynaptonemal complex length 1 (mouse)367907333128393649Mouse
11251721Ewc3_methanol withdrawal and consumption 3 (mouse)369568554103568554Mouse
1301791Char4_mP. chabaudi malaria resistance QTL 4 (mouse)Not determined369625509100655290Mouse
1301422Sle11_msystematic lupus erythematosus susceptibility 11 (mouse)Not determined370208904104209042Mouse
11049572Lmr11c_mleishmaniasis resistance 11c (mouse)372139967106140094Mouse
1300982Lmr11_mleishmaniasis resistance 11 (mouse)Not determined372139967106140094Mouse
1300595Tmevd2_mTheiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 2 (mouse)Not determined375463302109463549Mouse
1301392Eae3_msusceptibility to experimental allergic encephalomyelitis 3 (mouse)Not determined379548730113548837Mouse
1301947Pcfm3_mperiosteal circumference and femur length 3 (mouse)Not determined381084652115084797Mouse
1301904Iba2_minduction of brown adipocytes 2 (mouse)Not determined382147043116147184Mouse
11041900Lmr11a_mleishmaniasis resistance 11a (mouse)383463991117464137Mouse
11039510Ltpr3d_mLeishmania tropica response 3d (mouse)383463991117464137Mouse
11039511Ltpr3c_mLeishmania tropica response 3c (mouse)383463991117464137Mouse
11039507Ltpr3g_mLeishmania tropica response 3g (mouse)383463991117464137Mouse
11039508Ltpr3f_mLeishmania tropica response 3f (mouse)383463991117464137Mouse
11039509Ltpr3e_mLeishmania tropica response 3e (mouse)383463991117464137Mouse
11039512Ltpr3b_mLeishmania tropica response 3b (mouse)383463991117464137Mouse
1301272Cfsw1_mcystic fibrosis survival to weaning 1 (mouse)Not determined383882912117883044Mouse
4142099Cq3_mcholesterol QTL 3 (mouse)Not determined384888918118889067Mouse
14746984Manh54_mmandible shape 54 (mouse)385289152119289152Mouse
1357583Sle18_msystematic lupus erythematosus susceptibility 18 (mouse)Not determined387208904125316236Mouse
12738440Twq3_mtestis weight QTL 3 (mouse)387228015121228015Mouse
4142178Ctrq2_mC. trachomatis resistance QTL 2 (mouse)Not determined389139967137453008Mouse
10766455Sle22_msystematic lupus erythematosus susceptibility 22 (mouse)390376936124377072Mouse
14747001Mancz4_mmandible centroid size 4 (mouse)390378017124378017Mouse
1301398Rapop3_mradiation-induced apoptosis 3 (mouse)Not determined390511217100464137Mouse
1302052Etohcta4_methanol conditioned taste aversion 4 (mouse)Not determined391000105125008748Mouse
1301349Pgia26_mproteoglycan induced arthritis 26 (mouse)Not determined392251533126251650Mouse

Markers in Region
UniSTS:493011  
Mouse AssemblyChrPosition (strand)SourceJBrowse
GRCm38396,414,437 - 96,414,833UniSTSGRCm38
MGSCv37396,218,360 - 96,218,756UniSTSGRCm37
Celera397,832,081 - 97,832,477UniSTS
Cytogenetic Map3FUniSTS
PMC122568P1  
Mouse AssemblyChrPosition (strand)SourceJBrowse
GRCm38396,414,700 - 96,414,810UniSTSGRCm38
MGSCv37396,218,623 - 96,218,733UniSTSGRCm37
Celera397,832,344 - 97,832,454UniSTS
Cytogenetic Map3FUniSTS
PMC154048P1  
Mouse AssemblyChrPosition (strand)SourceJBrowse
GRCm38396,414,835 - 96,414,919UniSTSGRCm38
MGSCv37396,218,758 - 96,218,842UniSTSGRCm37
Celera397,832,479 - 97,832,563UniSTS
Cytogenetic Map3FUniSTS
PMC154048P2  
Mouse AssemblyChrPosition (strand)SourceJBrowse
GRCm38396,414,437 - 96,414,834UniSTSGRCm38
MGSCv37396,218,360 - 96,218,757UniSTSGRCm37
Celera397,832,081 - 97,832,478UniSTS
Cytogenetic Map3FUniSTS


Expression


Sequence


Reference Sequences
RefSeq Acc Id: ENSMUST00000082862
RefSeq Status:
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm38.p6 Ensembl396,414,437 - 96,414,859 (-)Ensembl
RefSeq Acc Id: ENSMUST00000238714
RefSeq Status:
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl396,321,753 - 96,322,149 (-)Ensembl
GRCm38.p6 Ensembl396,414,437 - 96,414,833 (-)Ensembl
RefSeq Acc Id: NR_001579
RefSeq Status: REVIEWED
Type: NON-CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39396,321,753 - 96,322,149 (-)NCBI
GRCm38396,414,437 - 96,414,833 (-)ENTREZGENE
MGSCv37396,218,360 - 96,218,756 (-)RGD
Celera397,832,081 - 97,832,477 (-)RGD
cM Map3 ENTREZGENE
Sequence:
Promoters
RGD ID:6834534
Promoter ID:MM_KWN:35382
Type:CpG-Island
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:3T3L1_Day0,   3T3L1_Day1,   3T3L1_Day2,   3T3L1_Day3,   3T3L1_Day4,   BoneMarrow_0Hour,   BoneMarrow_2Hour,   BoneMarrow_4Hour,   ES_Cell,   Liver,   Lung,   MEF_B4,   MEF_B6
Transcripts:NR_001579
Position:
Mouse AssemblyChrPosition (strand)Source
MGSCv36396,218,419 - 96,218,919 (-)MPROMDB
RGD ID:6881674
Promoter ID:EPDNEW_M4288
Type:multiple initiation site
Name:Terc_1
Description:Mus musculus telomerase RNA component , telomerase RNA.
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm38396,414,832 - 96,414,892EPDNEW
RGD ID:15092583
Promoter ID:EPDNEWNC_M501
Type:single initiation site
Name:Terc_1
Description:telomerase RNA component [Source:NCBI gene;Acc:21748]
SO ACC ID:SO:0000170
Source:EPDNEWNC (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm38396,414,832 - 96,414,892EPDNEWNC

Additional Information

Database Acc Id Source(s)
Ensembl Genes ENSMUSG00000064796 Ensembl
  ENSMUSG00000118406 Ensembl, ENTREZGENE
Ensembl Transcript ENSMUST00000238714 ENTREZGENE
MGD MGI:109558 ENTREZGENE
NCBI Gene 21748 ENTREZGENE
PhenoGen Terc PhenoGen
RNAcentral URS0000328DF6 RNACentral